Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:41 pm Purchase |
2024-12-31 | 13G | Oramed Pharmaceuticals Inc. ORMP |
BML Investment Partners, L.P. | 2,643,907 6.550% |
595,273 (+29.06%) |
Filing History |
| 2025-01-17 4:15 pm Purchase |
2025-01-13 | 13G | Scilex Holding Company SCLX |
ORAMED PHARMACEUTICALS INC. ORMP |
15,500,000 6.200% |
15,500,000 (New Position) |
Filing History |
| 2024-09-16 4:42 pm Purchase |
2024-09-10 | 13G | Oramed Pharmaceuticals Inc. ORMP |
BML Investment Partners, L.P. | 2,048,634 5.000% |
2,048,634 (New Position) |
Filing History |
| 2024-03-22 9:30 pm Purchase |
2024-03-06 | 13D | Oramed Pharmaceuticals Inc. ORMP |
KIDRON NADAV | 2,343,919 5.700% |
1,000,473 (+74.47%) |
Filing History |
| 2021-09-02 4:49 pm Sale |
2021-08-19 | 13D | Oramed Pharmaceuticals Inc. ORMP |
KIDRON NADAV | 1,343,446 4.100% |
-1,288,614 (-48.96%) |
Filing History |
| 2021-02-09 3:52 pm Purchase |
2020-12-31 | 13G | Oramed Pharmaceuticals Inc. ORMP |
Slager David Mark | 1,344,123 5.040% |
27,800 (+2.11%) |
Filing History |